RecruitingPhase 4NCT03230565

Continuous Infusions vs Scheduled Bolus Infusions

A Prospective Comparison of Pain and Analgesia in Patients With Continuous Peripheral Nerve Block Catheters Using Continuous Infusion or Scheduled Bolus Infusion

Sponsor

Stanford University

Enrollment

240 participants

Start Date

Jun 1, 2018

Study Type

INTERVENTIONAL

Conditions

Pain, Postoperative Surgical Procedure, Unspecified

Summary

The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ropivacaine and a drug called Ropivacaine for people with pain, postoperative and surgical procedure, unspecified. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.